Anzeige

2009: 102/1 (July) pp. 1-183

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

32 articles
1.
Venous thromboembolism prophylaxis: Quality, location (hospital vs. home), and duration

Samuel Z. Goldhaber

Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2009 102 1: 1-2

http://dx.doi.org/10.1160/TH09-05-0292

[Summary] [Free download]
2.
Ex-vivo thrombolytic gene therapy for vein graft patency: The frontier for development of selective, localised therapeutic approaches

Christoph E. Hagemeyer; Karlheinz Peter

Atherothrombosis and Vascular Biology, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia

Thrombosis and Haemostasis 2009 102 1: 3-4

http://dx.doi.org/10.1160/TH09-06-0343

[Summary] [Free download]
3.
Safety of venous ultrasound in suspected DVT – still a matter of concern?

Jan Beyer-Westendorf

University Clinic “Carl Gustav Carus”, Division of Vascular Medicine, Technical University Dresden, Dresden, Germany

Thrombosis and Haemostasis 2009 102 1: 5-6

http://dx.doi.org/10.1160/TH09-04-0233

[Summary] [Free download]
4.
[Add to basket]
Clopidogrel response variability: Current status and future directions

José Luis Ferreiro; Dominick J. Angiolillo

University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA

Thrombosis and Haemostasis 2009 102 1: 7-14

http://dx.doi.org/10.1160/TH09-03-0185

[Summary] [PDF] [Pay per view]
5.
Recent developments in topical thrombins

Craig M. Kessler1; Thomas L. Ortel2

1Division of Coagulation, Department of Laboratory Medicine, Georgetown University, Washington, DC, USA; 2Hemostasis and Thrombosis Center, Duke University, Durham, North Carolina, USA

Thrombosis and Haemostasis 2009 102 1: 15-24

http://dx.doi.org/10.1160/TH09-01-0034

[Summary] [Free download]
6.
[Add to basket]
Laboratory criteria of the obstetrical antiphospholipid syndrome - Data from a multicentric prospective European women cohort

Marie-Claire Boffa1; Catherine Boinot2; Sara De Carolis3; Patrizia Rovere-Querini4; Marie-Hélène Aurousseau1; Flavio Allegri5; Pascale Nicaise-Roland1,6; Anne Barra7; Angela Botta8; Ales Ambrozic9; Tadej Avcin10; Angela Tincani5

1Laboratoire d’Hématologie, Unité Hémostase et Thrombose, AP- Hôpitaux de Paris, Hôpital Jean-Verdier, Bondy, France; 2 Service d’Hématologie et Oncologie Biologique, Centre Hospitalier et Université de Poitiers, Poitiers, France; 3Department of Obstetrics and Gynecology, Catholic University, Rome, Italy; 4San Raffaele Scientific Institute, Milano, Italy; 5Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy; 6Immunologie, AP-HP Hôpital Bichat, Claude Bernard, Paris, France; 7Laboratoire d'Immunologie, Centre Hospitalier et Université de Poitiers, Poitiers, France; 8Department of Rheumatology and Immunology, Catholic University, Rome, Italy; 9Department of Rheumatology and Immunology, University Medical Center, Ljubljana, Slovenia; 10Pediatrics, University Medical Center, Ljubljana, Slovenia

Thrombosis and Haemostasis 2009 102 1: 25-28

http://dx.doi.org/10.1160/TH09-01-0043

[Summary] [PDF] [Pay per view]
7.
[Add to basket]
Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: Fibrinogen Mannheim V

Carl-Erik Dempfle1; Peter M.George2; Martin Borggrefe1; Michael Neumaier3; Stephen O. Brennan2

1University Hospital of Mannheim, I. Department of Medicine, Mannheim, Germany; 2Molecular Pathology Laboratory, Canterbury Health Laboratories, Christchurch Hospital, Christchurch, New Zealand; 3University Hospital of Mannheim, Department of Clinical Chemistry, Mannheim, Germany

Thrombosis and Haemostasis 2009 102 1: 29-34

http://dx.doi.org/10.1160/TH08-09-0559

[Summary] [PDF] [Pay per view]
8.
[Add to basket]
The comparative immunogenicity of human and porcine factor VIII in haemophilia A mice

John F. Healey1; Ernest T. Parker1; Rachel T. Barrow1; Travis J. Langley1; William R. Church2; Pete Lollar1

1Aflac Cancer Center and Blood Disorders Service, Department of Pediatrics, Children’s Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA; 2Green Mountain Antibodies, Burlington, Vermont, USA

Thrombosis and Haemostasis 2009 102 1: 35-41

http://dx.doi.org/10.1160/TH08-12-0818

[Summary] [PDF] [Pay per view]
9.
[Add to basket]
Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin

Grigoris T. Gerotziafas1,2; Charlotte Dupont1; Alex C. Spyropoulos3; Mohamed Hatmi4; Meyer M. Samama4; Dimitris Kiskinis5; Ismail Elalamy1,2

1Service d’Hématologie Biologique, Hôpital Tenon, Assistance Publique Hôpitaux de Paris, France; 2ER2UPMC, Faculty of Medicine, University Pierre and Marie Curie (Paris VI), France; 3Clinical Thrombosis Center, Lovelace Medical Center, Albuquerque, New Mexico, USA; 4Service d’Hématologie Biologique, Hôpital Hôtel Dieu, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie (Paris VI), France; 5Research Unit of Thrombosis and Vascular Biology, 1st Department of Surgery, Aristotle University of Thessaloniki, Papageorgiou general Hospital, Thessaloniki, Greece

Thrombosis and Haemostasis 2009 102 1: 42-48

http://dx.doi.org/10.1160/TH08-10-0653

[Summary] [PDF] [Pay per view]
10.
[Add to basket]
Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients

Krystyna Pawlak1; Michal Mysliwiec2; Dariusz Pawlak1,3

1Department of Monitored Pharmacotherapy, Medical University, Bialystok, Poland; 2Department of Nephrology and Clinical Transplantation, Medical University, Bialystok, Poland; 3Department of Medical Science, University of Warmia and Mazury, Olsztyn, Poland

Thrombosis and Haemostasis 2009 102 1: 49-55

http://dx.doi.org/10.1160/TH08-10-0696

[Summary] [PDF] [Pay per view]
11.
[Add to basket]
Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery - Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL)

Christoph Kalka1*; David Spirk2*; Klaus-Arno Siebenrock1; Urs Metzger3; Philipp Tuor4; Daniel Sterzing5; Kurt Oehy6; Daniela Wondberg7; El Yazid Mouhsine8; Emanuel Gautier9; Nils Kucher10

1University Hospital Berne, Switzerland; 2sanofi-aventis (suisse) sa Meyrin, Switzerland; 3City Hospital Triemli Zurich, Switzerland; 4City Hospital Waid Zurich, Switzerland; 5Cantonal Hospital Muensterlingen, Switzerland; 6Cantonal Hospital Frauenfeld, Switzerland; 7Cantonal Hospital Olten, Switzerland; 8University Hospital Lausanne, Switzerland; 9Cantonal Hospital Fribourg, Switzerland; 10University Hospital Zurich, Switzerland

Thrombosis and Haemostasis 2009 102 1: 56-61

http://dx.doi.org/10.1160/TH09-02-0097

[Summary] [PDF] [Pay per view]
12.
[Add to basket]
Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography - Comparison with unfractionated heparin and low-molecular-weight heparin

Helen M. Atkinson1,2; Tracy A. Mewhort-Buist1,2; Leslie R. Berry1,2; Anthony K. C. Chan1,2

1Henderson Research Centre, Hamilton, ON, Canada; 2Department of Pediatrics, McMaster University, Hamilton, ON, Canada

Thrombosis and Haemostasis 2009 102 1: 62-68

http://dx.doi.org/10.1160/TH08-11-0769

[Summary] [PDF] [Pay per view]
13.
[Add to basket]
Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitor

Jan Develter; Maarten Dewilde; Ann Gils; Paul J. Declerck

Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Belgium

Thrombosis and Haemostasis 2009 102 1: 69-75

http://dx.doi.org/10.1160/TH08-09-0834

[Summary] [PDF] [Pay per view]
14.
[Add to basket]
Absence of platelet-dependent fibrin formation in a patient with Scott syndrome

Simone J. H. Wielders1; Jos Broers2; Hugo ten Cate3; Peter W. Collins4; Edouard M. Bevers1; Theo Lindhout1

1Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; 2Department of Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; 3Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; 4Arthur Bloom Haemophilia Centre, University Hospital of Wales, Cardiff, United Kingdom

Thrombosis and Haemostasis 2009 102 1: 76-82

http://dx.doi.org/10.1160/TH08-11-0719

[Summary] [PDF] [Pay per view]
15.
[Add to basket]
Binding of plasma factor XIII to thrombin-receptor activated human platelets

Béla Nagy Jr1; Zsuzsa Simon1; Zsuzsa Bagoly2; László Muszbek2; János Kappelmayer1

1Department of Clinical Biochemistry and Molecular Pathology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary; 2Clinical Research Center and Thrombosis, Haemostasis and Vascular Biology Research Group, Hungarian Academy of Sciences, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary

Thrombosis and Haemostasis 2009 102 1: 83-89

http://dx.doi.org/10.1160/TH09-01-0054

[Summary] [PDF] [Pay per view]
16.
[Add to basket]
Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation

Alessandro Pecci1; Alessandro Malara2; Stefania Badalucco2; Valeria Bozzi1; Mauro Torti2; Carlo L. Balduini1; Alessandra Balduini2

1Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy; 2Department of Biochemistry, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy

Thrombosis and Haemostasis 2009 102 1: 90-96

http://dx.doi.org/10.1160/TH09-01-0068

[Summary] [PDF] [Pay per view]
17.
[Add to basket]
Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and α-granule release

Sybille Rex1,2; Lea M. Beaulieu1; David H. Perlman2; Olga Vitseva1; Price S. Blair1; Mark E. McComb2; Catherine E. Costello2,3; Jane E. Freedman1,2

1Whitaker Cardiovascular Institute, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA; 2Cardiovascular Proteomics Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA; 3Mass Spectrometry Resource and Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, USA

Thrombosis and Haemostasis 2009 102 1: 97-110

http://dx.doi.org/10.1160/TH08-08-0513

[Summary] [PDF] [Pay per view]
18.
[Add to basket]
The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease

Victor L. Serebruany1; Motoji Kogushi2; Daniela Dastros-Pitei3; Marcus Flather4; Deepak L. Bhatt5

1HeartDrug™ Research Laboratories, Johns Hopkins University Baltimore, MD, USA; 2Innovative Biology Laboratories, Eisai Co. Ltd., Tsukuba, Japan; 3Eisai Global Clinical Development, Eisai Limited, London, UK; 4Royal Brompton Hospital and Imperial College, London, UK; 5VA Boston Healthcare System and Brigham and Women’s Hospital, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2009 102 1: 111-119

http://dx.doi.org/10.1160/TH08-12-0805

[Summary] [PDF] [Pay per view]
19.
[Add to basket]
The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy

- See additional contents by clicking on [Summary] -

Yuxi Feng1; Franziska vom Hagen1; Yumei Wang1; Susanne Beck2; Kay Schreiter3; Frederick Pfister1; Sigrid Hoffmann4; Patrick Wagner5; Mathias Seeliger2; Grietje Molema6; Urban Deutsch7; Hans-Peter Hammes1

15th Medical Clinic, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; 2Retinal Electrodiagnostics Research Group, University of Tuebingen, Tuebingen, Germany; 3DeveloGen AG, Göttingen, Germany; 4Medical Research Center, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; 5Max-Planck-Institute for Physiological and Clinical Research, Bad Nauheim, Germany; 6Laboratory for Endothelial Biomedicine and Vascular Drug Targeting Research, Medical Biology Section, Department Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; 7Max-Planck-Institute for Vascular Biology, c/o Institute of Cell Biology, ZMBE, University of Muenster, and Theodor-Kocher-Institute, Berne, Switzerland

Thrombosis and Haemostasis 2009 102 1: 120-130

http://dx.doi.org/10.1160/TH08-09-0567

[Summary] [PDF] [Pay per view]
20.
[Add to basket]
Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level

Véronique Le Cam-Duchez1,2; Claudine Soria2,3; Claire Bal dit Sollier3; Jeanne-Yvonne Borg1,2; Mathieu Coudert4,5; Gilles Montalescot6; Gaétan Esposito3; Ludovic Drouet3; Jean-Philippe Collet6

1Unit of Vascular Haemostasis, Rouen University Hospital, Rouen, France; 2EA3829 (Research Group MERCI), Institute for Biomedical Research, University of Rouen, Rouen, France; 3Haematology Laboratory, Lariboisière University Hospital, Paris, France; 4APHP, Pitié-Salpêtrière Charles-Foix Clinical Research Unit, Paris, France; 5UPMC Univ. Paris 06, EA 3974, Modelling in Clinical Research, Paris, France; 6Department of Cardiology, Pitié-Salpêtrière University Hospital, Paris, France

Thrombosis and Haemostasis 2009 102 1: 131-136

http://dx.doi.org/10.1160/TH09-01-0007

[Summary] [PDF] [Pay per view]
  1-20 21-32
Next page

Articles

You've 98 Article(s) in your Basket.

Thrombosis News

TH107.2

With the expiry or pending expiry of originator low-molecular-weight heparin (LMWH) patents,...

TH 107.1

T&H has a new type of article! Read the first T&H Insights article by Lutgens et al. in the...

TH 106.6

Read the important position document from the European Heart Rhythm Association [EHRA] and the...